Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Synergy Pharmaceuticals Inc    

SYNERGY PHARMACEUTICALS INC

My previous session
Most popular
  Report  
 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials (USD)
More Financials
Company
Synergy Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of gastrointestinal (GI) therapies. The Company's product candidates include TRULANCE (plecanatide) and dolcanatide. The Company is engaged in the discovery, research and development efforts... 
More about the company
Latest news on SYNERGY PHARMACEUTICALS IN
03/14SYNERGY PHARMACEUTICALS, INC. : Bankruptcy or Receivership, Financial Statements..
AQ
03/08SYNERGY PHARMACEUTICALS, INC. : Notice of Delisting or Failure to Satisfy a Cont..
AQ
03/06SYNERGY PHARMACEUTICALS, INC. : Completion of Acquisition or Disposition of Asse..
AQ
03/06SYNERGY PHARMACEUTICALS : Announces Completion of Sale to Bausch Health
PR
03/04SYNERGY PHARMACEUTICALS : Receives Court Approval for the Sale of Its Assets to ..
AQ
03/04SYNERGY PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements a..
AQ
03/01SYNERGY PHARMACEUTICALS : Is Approved to Sell Assets to Bausch Health
DJ
03/01SYNERGY PHARMACEUTICALS : Receives Court Approval for the Sale of Its Assets to ..
PR
02/27SYNERGY PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Other..
AQ
02/27BAUSCH HEALTH : to Acquire Certain Assets of Synergy Pharmaceuticals Inc
AQ
More news
Sector news : Bio Therapeutic Drugs
03/11Regeneron Says FDA Approves Dupixent for Atopic Dermatitis in Adolescents
DJ
03/08Regeneron, Sanofi Get FDA Priority Review for Dupixent
DJ
03/07SHANGHAI RAAS BLOOD PRODUCTS : Spain's Grifols, China's Shanghai RAAS form strat..
RE
03/06GILEAD SCIENCES : Says Once-Daily HIV Regimen Shows Promise in Treating Teens an..
DJ
03/05FDA Approves Controversial Drug for Depression -- Update
DJ
More sector news : Bio Therapeutic Drugs
Chart SYNERGY PHARMACEUTICALS INC
Duration : Period :
Synergy Pharmaceuticals Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
 
Mean consensus
Number of Analysts
Average target price -
Spread / Average Target -100%
EPS Revisions
Managers
NameTitle
Troy Hamilton Chief Executive Officer & Director
Melvin K. Spigelman Chairman
Gary G. Gemignani Secretary, CFO, Principal Accounting Officer & EVP
Patrick H. Griffin Chief Medical Officer & Executive Vice President
John P. Brancaccio Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SYNERGY PHARMACEUTICALS INC-73.66%3
GILEAD SCIENCES1.95%81 339
VERTEX PHARMACEUTICALS9.55%46 409
REGENERON PHARMACEUTICALS4.90%42 066
GENMAB8.01%10 747
SAREPTA THERAPEUTICS INC12.03%9 008